Position in FLGT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$170,607
-$145,316 QoQ
Shares Held
10,730
-10.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $584,341,661 across 19 Diagnostics & Research names. FLGT ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,214,467 | $230,262,943 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
222,589 | $109,409,171 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
594,800 | $102,603,000 | |
| 4 | WAT |
Waters Corp /De/
|
145,950 | $43,463,910 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
45,739 | $25,700,286 | |
| 6 | DGX |
Quest Diagnostics Inc
|
126,510 | $24,793,429 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
56,982 | $9,717,710 | |
| 8 | A |
Agilent Technologies, Inc.
|
80,960 | $9,227,820 |
All Filings in FLGT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $170,607 | 10,730 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $315,923 | 12,026 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $274,703 | 12,155 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $217,387 | 10,935 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||